<DOC>
	<DOCNO>NCT02327663</DOCNO>
	<brief_summary>This study evaluate generic emtricitabine ( FTC ) Chinese naive chronic hepatitis B patient . Patients divide 2 group : HBeAg positive Chronic hepatitis B ( CHB ) group HBeAg negative Chronic hepatitis B ( CHB ) group .</brief_summary>
	<brief_title>Emtricitabine Naive Chinese Chronic Hepatitis B Patients</brief_title>
	<detailed_description>Generic emtricitabine ( FTC ) approve treatment naive chronic hepatitis B ( CHB ) patient China . Yet data limit agent . The investigator design trial test effect FTC Chinese CHB include naive HBeAg positive Negative CHB patient . Response guide therapy strategy adopt patient achieve HBV DNA negativity week 24 FTC treatment , mean FTC adefovir combine patient .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Adefovir</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Adefovir dipivoxil</mesh_term>
	<criteria>HBsAg positive 6 month HBeAg positive patient : HBV DNA ≥ 5log10 copies/ml HBeAg postive patient : ALT≥2×ULN ; liver biopsy G≥2 ; liver biopsy S ≥2 ; liver biopsy Knodell HAI ≥ 4 HBeAg negative patient : HBV DNA ≥ 4log10 copies/ml HBeAg postive patient : ALT≥2×ULN ; liver biopsy G≥2 ; liver biopsy S ≥2 ; liver biopsy Knodell HAI ≥ 4 nucleoside/nucleotide naive paitents Diagnosed HCC AFP ultrasound , CT MRI Creatine ＞130μmol/L Ccr &lt; 70mL/min Hemoglobin &lt; 100g/L Neutrophils &lt; 1.5E+9/L PLT &lt; 80E+9/L Coinfected HAV , HEV , HCV , HDV HIV ANA ＞ 1:100 Uncontrolled cardiovascluar disease , kidney disease , lung disease , neurological disease , digestive disease , metabolic disorder , immunecompromised disease cancer Drug abuse alcohal addiction Previous history take agent lamivudine , adefovir , tenofovir entecavir telbivudine Longterm use immunosuppressor immunomodulator 6 month enrollment trial Underwent liver transplantation liver transplantation schedule Allergic nucleoside nucleotide analogues Preganency breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Hepatitis B , chronic</keyword>
	<keyword>Emtricitabine</keyword>
	<keyword>Adefovir dipivixil</keyword>
	<keyword>HBeAg</keyword>
</DOC>